Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: A randomized controlled trial

Journal of Family Practice

Volumn 51, Issue 12, 2002, Pages 1049-1055

  Rabago, David ^a,b   Zgierska, Aleksandra ^a   Mundt, Marlon ^a   Barrett, Bruce ^a   Bobula, James ^a   Maberry, Rob ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NONE   (United States)

Author keywords

Nasal irrigation; Quality of life; Sinusitis

Indexed keywords

HYPERTONIC SOLUTION; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LAVAGE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINUSITIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; IRRIGATION; MALE; MIDDLE AGED; QUALITY OF LIFE; SALINE SOLUTION, HYPERTONIC; SINUSITIS;

EID: 0036898520     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ray NF. Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: Contributions of asthma, rhinitis and other airway disorders. J Allergy Clin Immunol 1999; 103:408-14.
2. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273:214-9.
3. Centers for Disease Control. Vital and Health Statistics. Current Estimates From the National Health Interview Survey. 1994. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Center for Health Statistics, 1995. DHHS publication PHS 96-1521.
4. Glicklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995; 113:104-9.
5. Kaliner MA, Osuguthorpe JD, Fireman P, et al. Sinusitis bench to bedside: Current findings, future directions. J Allergy Clin Immunol 1997; 99: S829-47.
6. Druce HM. Adjuncts to medical management of sinusitis. Otolaryngol Head Neck Surg 1990; 103:880-3.
7. Zieger RS. Prospects for ancillary treatment of sinusitis in the 1990's. J Allergy Clin Immunol 1992; 90: 478-93.
8. Talbot AR, Herr TM, Parsons DS. Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope 1997; 107:500-3.
9. Robinson M, Hemming AL, Regnis JA, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997; 52:900-3.
10. Homer JJ, Dowley AC, Condon L, El-Jassar P. Sood S. The effect of hypertonicity on nasal mucociliary clearance. CIin Otolaryngol 2000; 25:558-60.
11. Homer JJ, England RJ, Wilde AD, Harwood GRJ, Stafford ND. The effect of pH of douching solution on mucociliary clearance. Clin Otolaryngol 1999; 24:312-5.
12. Heatley DG. McConnell KE, Kille TL, Leverson GE. Nasal irrigation for the alleviation of sinonasaI symptoms. Otolaryngol Head Neck Surg 2001; 125:44-8,
13. Tamooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation, Laryngoscope 2000; 110: 1189-93.
14. Taccariello M, Parikh A, Darby Y, Scadding G. Nasal douching as a valuable, adjunct in the management of chronic rhinosinusitis. Rhinology 1999; 37:29-32
15. Bachmann G. Hommel G, Michel O. Effect of irrigation of the nose with isotonic salt solution on patients with chronic paranasal sinus disease. Eur Arch Otorhinolaryngol 2000; 257:53741.
16. Shoseyov D, Bibi H, Shai P, et al. Treatment with hypertonic saline versus normal saline wash of pediatric chronic sinusitis. J Allergy Clin Immunol 1998; 101:602-5.
17. Rabone SJ, Saraswari SB. Acceptance and effects of nasal lavage in volunteer woodworkers. Occupat Med 1999; 49:3659.
18. Holmstrom M, Rosen G. Walander L. Effect of nasal lavage on nasal symptoms and physiology in wood industry workers. Rhinology 1997; 35:108-12.
19. SinuCleanse, Med Systems, April 22, 2002. Available at: http://www.sinucleanse.com. Accessed October 7, 2002.
20. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary test of reliability and validity. Med Care 1996; 34:220-6.
21. Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolyryngol Head Neck Surg 1997; 123: 1175-9.
22. Guyatt GH, Bombardier C, Tugwell P. Measuring disease-specific quality of life in clinical trials. CMAJ 1986; 134:889-95.
23. Senior BA, Glaze C. Benninger MS. Use of the Rhinosinusitis Disability Score (RSDI) in rhinologic disease. Am J Rhinol 2001; 15:15-20.
24. Deyo RA, Patrick DL The significance of treatment effects: The clinical perspective. Med Care 1995: 33:AS286-91.
25. Redelmeier DA, Guyatt GH. Goldstein RS. Assessing the minimal important difference in symptoms: A comparison of two techniques. J Clin Epidemiol 1996; 49:1215-9.
26. Samsa G. How should the minimum important difference for a health-related quality-of-life instrument be estimated? Med Care 2001; 39:1037-8.
27. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10:407-15.
28. Bellamy N, Carr A, Dougados M, Shea B, Wells G Towards a definition of "difference" in osteoarthritis. J Rheumatol 2001; 28:427-30.
29. Powell CV, Kelly A-M. Determining the minimum clinically significant difference in visual analog pain score for children Ann Emerg Med 2001: 37:28-31.
30. Todd KH, Funk JP. The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med 1996; 3:142-6.
31. Wells GA, Tugwell P, Kraag GR, et al. Minimum important difference between patients with rheumatoid arthritis: The patient's perspective. J Rheumatol 1993; 20:557-60.
32. Wendeler HM, Muller J, Dieler R, Helms J. Nasenspuling mit isotoner Emser-Salz-Losung bei chronischer rhinosinusitis. Otorhinolaryngol Nova 1997; 7:254-8.